PSK and Trx80 inhibit B-cell growth in EBV-infected cord blood mononuclear cells through T cells activated, by the monocyte products IL-15 and IL-12

Blood

Volumn 105, Issue 4, 2005, Pages 1606-1613

  Liu, Anquan ^a   Arbiser, Jack L ^b   Holmgren, Arne ^b   Klein, George ^b   Klein, Eva ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 12; INTERLEUKIN 15; KRESTIN; PHOSPHATIDYLINOSITOL 3 KINASE; REACTIVE OXYGEN METABOLITE; SIGNALING LYMPHOCYTE ACTIVATION MOLECULE ASSOCIATED PROTEIN; THIOREDOXIN; THIOREDOXIN 80; UNCLASSIFIED DRUG;

ARTICLE; B LYMPHOCYTE; CELL SEPARATION; CYTOKINE PRODUCTION; CYTOTOXICITY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; IMMUNOLOGICAL MEMORY; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE TRANSFORMATION; MACROPHAGE; MONOCYTE; MONONUCLEAR CELL; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; UMBILICAL CORD BLOOD;

EID: 13544264408     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-06-2406     Document Type: Article

References (41)

1. Rickinson AB, Kieff E. Epstein-Barr virus. In: Knipe DM, Howley PM, eds. Fields virology. 4th ed. Philadelphia, PA: Lippincott, Williams, Raven. 2001:2575-2627.
2. Thorley-Lawson DA, Gross A. Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med. 2004;350:1328-1337.
3. Levitsky V, Masucci MG. Manipulation of immune responses by Epstein-Barr virus. Virus Res. 2002;88:71-86.
4. Rickinson AB, Moss DJ. Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. Annu Rev Immunol. 1997;15:405-431.
5. + Epstein-Barr virus-specific cytotoxic T-lymphocytes from human umbilical cord blood. Cell Immunol. 1999;195:81-88.
6. Wilson AD, Morgan AJ. Primary immune responses by cord blood CD4 (+) T cells and NK cells inhibit Epstein-Barr virus B-cell transformation in vitro. J Virol. 2002;76:5071-5081.
7. Moretta A, Comoli P, Montagna D, et al. High frequency of Epstein-Barr virus (EBV) lymphoblastoid cell line-reactive lymphocytes in cord blood: evaluation of cytolytic activity and IL-2 production. Clin Exp Immunol. 1997;107:312-320.
8. Vanky F, Wang P, Klein E. The polysaccharide K (PSK) potentiates in vitro activation of the cytotoxic function in human blood lymphocytes by autologous tumour cells. Cancer Immunol Immunother. 1992;35:193-198.
9. Fisher M, Yang LX. Anticancer effects and mechanisms of polysaccharide K (PSK): implications of cancer immunotherapy. Anticancer Res. 2002;22:1737-1754.
10. Liu A, Klein G, Bandobashi K, et al. SH2D1A expression reflects activation of T and NK cells in cord blood lymphocytes infected with EBV and treated with the immunomodulator PSK. Immunol Lett. 2002;80:181-188.
11. Fehniger TA, Caligiuri MA. Interleukin 15: biology and relevance to human disease. Blood. 2001;97: 14-32.
12. Gosselin J, Tomolu A, Gallo RC, Flamand L. Interleukin-15 as an activator of natural killer cell-mediated antiviral response. Blood. 1999;94: 4210-4219.
13. Pekkari K, Avila-Carino J, Bengtsson A, et al. Truncated thioredoxin (Trx80) induces production of interleukin-12 and enhances CD14 expression in human monocytes. Blood. 2001;97:3184-3190.
14. Pekkari K, Holmgren A. Truncated thioredoxin: physiological functions and mechanism. Antioxid Redox Signal. 2004;6:53-61.
15. Pekkari K, Gurunath R, Arnér ESJ, Holmgren A. Truncated thioredoxin is a mitogenic cytokine for resting human peripheral blood mononuclear cells and is present in human plasma. J Biol Chem. 2000;275:37474-37480.
16. Freundlich B, Avdalovic N. Use of gelatin/plasma coated flasks for isolating human peripheral blood monocytes. J Immunol Methods. 1983;62:31-37.
17. Masucci MG, Bejarano MT, Masucci G, Klein E. Large granular lymphocytes inhibit the in vitro growth of autologous Epstein-Barr virus-infected B cells. Cell Immunol. 1983;76:311-321.
18. Nagy N, Cerboni C, Mattsson K, et al. SH2D1A and SLAM protein expression in human lymphocytes and derived cell lines. Int J Cancer. 2000; 88:439-447.
19. Khanolkar A, Yagita H, Cannon MJ. Preferential utilization of the perforin/granzyme pathway for lysis of Epstein-Barr virus-transformed lymphoblastoid cells by virus-specific CD4+ T cells. Virology. 2001;287:79-88.
20. Fu Z, Cannon MJ. Functional analysis of the CD4(+) T-cell response to Epstein-Barr virus: T-cell-mediated activation of resting B cells and induction of viral BZLF1 expression. J Virol. 2000; 74:6675-6679.
21. Bhatt NY, Kelley TW, Khramtsov VV, et al. Macrophage-colony-stimulating factor-induced activation of extracellular-regulated kinase involves phosphatidylinositol 3-kinase and reactive oxygen species in human monocytes. J Immunol. 2002;169:6427-6434.
22. Zeng X, Dai J, Remick DG, Wang X. Homocysteine mediated expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human monocytes. Circ Res. 2003;93: 311-320.
23. Nikiforow S, Bottomly K, Miller G. CD4+ T-cell effectors inhibit Epstein-Barr virus-induced B-cell proliferation. J Virol. 2001;75:3740-3752.
24. Savoldo B, Cubbage ML, Durett AG, et al. Generation of EBV-specific CD4+ cytotoxic T cells from virus naive individuals. J Immunol. 2002; 168:909-918.
25. Kiener PA, Moran-Davis P, Rankin BM, Wahl AF, Aruffo A, Hollenbaugh D. Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes. J Immunol. 1995;155:4917-4925.
26. Peng X, Kasran A, Warmerdam PAM, Boer M, Ceuppens JL. Accessory signalling by CD40 for T cell activation: induction of Th1 and Th2 cytokines and synergy with interleukin-12 for IFN-gamma production. Eur J Immunol. 1996;26:1621-1627.
27. Snijders A, Kalinski P, Hilkens CM, Kapsenberg ML. High-level IL-12 production by human dendritic cells requires two signals. Int Immunol. 1998;10:1593-1598.
28. Hochrein H, O'Keeffe M, Luft T, et al. Interleukin (IL)-4 is a major regulatory cytokine governing bioactive IL-12 production by mouse and human dendritic cells. J Exp Med. 2000;192:823-833.
29. Kanazawa M, Mori Y, Yoshihara K, et al. Effect of PSK on the maturation of dendritic cells derived from human peripheral blood monocytes. Immunol Lett. 2004;91:229-238.
30. Sharif-Askari E, Fawaz LM, Tran P, Ahmad A, Menezes J. Interleukin 15-mediated induction of cytotoxic effector cells capable of eliminating Epstein-Barr virus-transformed/immortalized lymphocytes in culture. J Natl Cancer Inst. 2001;93: 1724-1732.
31. Lee SM, Suen Y, Qian J, et al. The regulation and biological activity of interleukin 12. Leuk Lymphoma. 1998;29:427-438.
32. Chan SH, Perussia B, Gupta JW, et al. Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J Exp Med. 1991;173:869-879.
33. Sahaf B, Rosen A. Secretion of 10-kDa and 12-kDa thioredoxin species from blood monocytes and transformed leukocytes. Antioxid Redox Signal. 2000;2:717-726.
34. Holmgren A. Thioredoxin. Annu Rev Biochem. 1985;54:237-271.
35. Arner ESJ, Holmgren A. Physiological functions of thioredoxin and thioredoxin reductase. Eur J Biochem. 2000;267:6102-6109.
36. Pekkari K, Avila-Carino J, Gurunath R, Bengtsson A, Scheynius A, Holmgren A. Truncated thioredoxin (Trx80) exerts unique mitogenic cytokine effects via a mechanism independent of thiol oxido-reductase activity. FEBS Letters. 2003;539: 143-148.
37. Sahaf B, Soderberg A, Spyrou G, et al. Thioredoxin expression and localization in human cell lines: detection of full-length and truncated species. Exp Cell Res. 1997;236:181-192.
38. Bertini R, Howard ZOM, Oppenheim JJ, et al. Thioredoxin, a redox enzyme released in infection and inflammation, is a unique chemoattractant for neutrofils, monocytes and T-cells. J Exp Med. 1999;189:1783-1789.
39. Tagaya Y, Maeda Y, Mitsui A, et al. ATL-derived factor (ADF), an IL-2 receptor/Tac inducer homologous to thioredoxin: possible involvement of dithiol-reduction in the IL-2 receptor induction. EMBO J. 1989;8:757-764.
40. Wakasugi N, Tagaya Y, Waksugi H, et al. Adult T-cell leukemia-derived factor/thioredoxin, produced by both T-lympocyte virus type I- and Epstein-Barr virus-transformed lymphocytes, acts as an autocrine growth factor and synergizes with interleukin 1 and interleukin 2. Proc Natl Acad Sci U S A. 1990;87:8282-8286.
41. Rosen A, Lundman P, Carlssson M, et al. A CD4+ T cell line-secreted factor, growth promoting for normal and leukemic B cells, identified as thioredoxin. Int Immunol. 1995;7:625-633.